GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Gross-Profit-to-Asset %

Asia Green Biotechnology (XCNQ:ASIA) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Asia Green Biotechnology's annualized Gross Profit for the quarter that ended in Mar. 2024 was C$0.00 Mil. Asia Green Biotechnology's average Total Assets over the quarter that ended in Mar. 2024 was C$0.07 Mil. Therefore, Asia Green Biotechnology's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.00%.


Asia Green Biotechnology Gross-Profit-to-Asset % Historical Data

The historical data trend for Asia Green Biotechnology's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology Gross-Profit-to-Asset % Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial - - - - -

Asia Green Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Asia Green Biotechnology's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Green Biotechnology's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's Gross-Profit-to-Asset % falls into.



Asia Green Biotechnology Gross-Profit-to-Asset % Calculation

Asia Green Biotechnology's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0/( (0.068+0.065)/ 2 )
=0/0.0665
=0.00 %

Asia Green Biotechnology's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0/( (0.065+0.067)/ 2 )
=0/0.066
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Asia Green Biotechnology Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Asia Green Biotechnology (XCNQ:ASIA) Business Description

Traded in Other Exchanges
N/A
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.
Executives
Johannes Kingma Senior Officer

Asia Green Biotechnology (XCNQ:ASIA) Headlines